Latest filing published 18 Jan 2024 for AN2 Therapeutics, Inc., €286k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -37.2%Entry US$15.79 · Close at T+365 US$9.91
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Adjuvant Global Health Technology Fund, L.P.: trading record in brief
Adjuvant Global Health Technology Fund, L.P. is a declared insider of AN2 Therapeutics, Inc., with filings sourced from SEC (Form 4). In total, 32 filings cover trades dated from 29 March 2022 to 16 January 2024.
Both buying and selling appear: 2 purchases worth €4.5M, against 20 sales worth €3.7M. Taken together, the purchases exceed the sales by €809k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. In 2024 alone, the filings show no purchases and 2 sales.
The newest entry dates from 18 January 2024: an open-market sale of €286k, in AN2 Therapeutics, Inc. The latest purchase dates back some time: it was published 1,599 days ago, on 24 June 2022. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Adjuvant Global Health Technology Fund, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 15,907 shares@ US$19.654.5% of flowCommon StockSEC:0000950170-24-005513:1
- 84,093 shares@ US$19.6542.1% of flowCommon StockSEC:0000950170-24-005513:0
- 288 shares@ US$16.1460.1% of flowCommon StockSEC:0000950170-23-064611:1
- 1,522 shares@ US$16.1460.6% of flowCommon StockSEC:0000950170-23-064611:0
- 83,337 shares@ US$16.2835.8% of flowCommon StockSEC:0000950170-23-051728:0
- 15,764 shares@ US$16.286.8% of flowCommon StockSEC:0000950170-23-051728:1
- 4,770 shares@ US$16.072.0% of flowCommon StockSEC:0000950170-23-051728:2
- 902 shares@ US$16.070.4% of flowCommon StockSEC:0000950170-23-051728:3
- 134 shares@ US$16.070.0% of flowCommon StockSEC:0000950170-23-050853:1
- 7,160 shares@ US$16.111.7% of flowCommon StockSEC:0000950170-23-050853:2
- 1,356 shares@ US$16.110.3% of flowCommon StockSEC:0000950170-23-050853:3
- 707 shares@ US$16.070.3% of flowCommon StockSEC:0000950170-23-050853:0
- 64 shares@ US$16.000.0% of flowCommon StockSEC:0000950170-23-048422:1
- ▼
Same trade as the filing by Kabeer Aziz, counted once
5,376 USD14SEC336 shares@ US$16.000.1% of flowCommon StockSEC:0000950170-23-048422:0 - 598 shares@ US$16.020.1% of flowCommon StockSEC:0000950170-23-047312:1
- 2,841 shares@ US$16.050.7% of flowCommon StockSEC:0000950170-23-047312:2
- 537 shares@ US$16.050.1% of flowCommon StockSEC:0000950170-23-047312:3
- 3,164 shares@ US$16.021.3% of flowCommon StockSEC:0000950170-23-047312:0
- 64 shares@ US$16.000.0% of flowCommon StockSEC:0000950170-23-044594:1
- ▼
Same trade as the filing by Kabeer Aziz, counted once
5,376 USD14SEC336 shares@ US$16.000.1% of flowCommon StockSEC:0000950170-23-044594:0 - 312,415 sharesCommon StockSEC:0000899243-22-024034:1
- 392,433 sharesCommon StockSEC:0000899243-22-024034:2
- 74,230 sharesCommon StockSEC:0000899243-22-024034:3
- 1,651,636 sharesCommon StockSEC:0000899243-22-024034:0
- 26,511 shares@ US$15.000.23% mcap10.4% of flowCommon StockSEC:0000899243-22-024050:0
25 of 28 declarations
